EyePoint Pharmaceuticals (NASDAQ:EYPT) reported its Q1 earnings results on Wednesday, May 3, 2023 at 07:00 AM.
Here’s what investors need to know about the announcement.
Earnings
EyePoint Pharmaceuticals beat estimated earnings by 17.65%, reporting an EPS of $-0.56 versus an estimate of $-0.68.
Revenue was down $1.61 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 12.8% increase in the share price the next day.
Here’s a look at EyePoint Pharmaceuticals’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.61 | -0.70 | -0.52 | -0.58 |
| EPS Actual | -0.61 | -0.49 | -0.52 | -0.56 |
| Revenue Estimate | 10.40M | 10.64M | 10.87M | 9.89M |
| Revenue Actual | 10.53M | 10.01M | 11.56M | 9.29M |
To track all earnings releases for EyePoint Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
